US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Immunovant, Inc.

25.36

+0.60002.42%

Post-market: 25.360.00000.00%16:20 EDT

Volume:1.04M

Turnover:26.21M

Market Cap:5.16B

PE:-9.46

High:25.84

Open:24.35

Low:24.30

Close:24.76

52wk High:29.25

52wk Low:12.72

Shares:203.53M

Float Shares:89.02M

Volume Ratio:0.58

T/O Rate:1.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.6799

EPS(LYR):-2.7303

ROE:-69.35%

ROA:-41.33%

PB:5.23

PE(LYR):-9.29

Loading ...

Overview Company News Filings

J.P. Morgan Sticks to Their Buy Rating for Immunovant (IMVT)

H.C. Wainwright Reaffirms Their Buy Rating on Immunovant (IMVT)

Immunovant (IMVT): Assessing Valuation After Earnings Beat and Encouraging Graves’ Disease Study Update

Simply Wall St.

Stock Track | Immunovant Shares Plummet 8.01% on Q2 Earnings Miss and Clinical Trial Result Delays

Stock Track | Immunovant Plummets 8.01% on Q2 Earnings Miss and Delayed Clinical Trial Results

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires Live

Stock Track | Immunovant Plunges 5.78% Pre-Market on Q2 Earnings Miss and Clinical Trial Updates

Immunovant Fiscal Q2 Loss Narrows

MT Newswires Live

Autoimmune drugmaker Immunovant's Q2 net loss misses estimates

Earnings Flash (IMVT) Immunovant Posts Fiscal Q2 Loss $0.73 a Share, vs. FactSet Est of $0.70 Loss

MT Newswires Live

Biopharma Roivant's Q2 income from operations misses

Immunovant Q2 EPS $(0.73) Misses $(0.72) Estimate

Immunovant reports cash and cash equivalents of $521.9 million as of September 30, 2025

Roivant Sciences posts $113.5 million net loss for quarter ended September 30, 2025

BRIEF-Immunovant Q2 Net Income USD -126.502 Million Vs. IBES Estimate USD -124.1 Million

Immunovant Inc: Co Anticipates Sharing Topline Results From Both Ted Studies Concurrently in First Half of Calendar Year 2026

THOMSON REUTERS

Immunovant Inc: on Track for First of Two Bataclimab Phase 3 Ted Study Readout Before End of Calendar Year 2025

THOMSON REUTERS

Press Release: Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025

Immunovant (IMVT) Receives a Buy from H.C. Wainwright

Immunovant CEO Eric Venker Reports Disposal of Roivant Sciences Ltd. Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IMVT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMVT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMVT\",,,,,undefined,":{"symbol":"IMVT","market":"US","secType":"STK","nameCN":"Immunovant, Inc.","latestPrice":25.36,"timestamp":1774555200000,"preClose":24.76,"halted":0,"volume":1035295,"hourTrading":{"tag":"盘后","latestPrice":25.36,"preClose":25.36,"latestTime":"16:20 EDT","volume":14301,"amount":362673.36,"timestamp":1774556400509,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02423263327948295,"floatShares":89017500,"shares":203532180,"eps":-2.679914,"marketStatus":"Not Yet Opened","change":0.6,"latestTime":"03-26 16:00:00 EDT","open":24.35,"high":25.84,"low":24.3,"amount":26214538.563092,"amplitude":0.062197,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.679914,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774598400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":24.76,"preHourTrading":{"tag":"盘前","latestPrice":24.4,"preClose":24.76,"latestTime":"08:41 EDT","volume":775,"amount":19099.5929,"timestamp":1774528866401,"change":-0.36,"changeRate":-0.01454,"amplitude":0.070679},"postHourTrading":{"tag":"盘后","latestPrice":25.36,"preClose":25.36,"latestTime":"16:20 EDT","volume":14301,"amount":362673.36,"timestamp":1774556400509,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.57757,"impliedVol":0.6032,"impliedVolPercentile":0.704},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMVT\",,,,,undefined,":{"symbol":"IMVT","floatShares":89017500,"roa":"-41.33%","roe":"-69.35%","lyrEps":-2.730291,"volumeRatio":0.57757,"shares":203532180,"dividePrice":0,"high":25.84,"amplitude":0.062197,"preClose":24.76,"low":24.3,"week52Low":12.72,"pbRate":"5.23","week52High":29.25,"institutionHeld":0,"latestPrice":25.36,"eps":-2.679914,"divideRate":0,"volume":1035295,"delay":0,"ttmEps":-2.679914,"open":24.35,"prevYearClose":25.42,"prevWeekClose":22.98,"prevMonthClose":27.73,"prevQuarterClose":25.42,"fiveDayClose":23.65,"twentyDayClose":27.41,"sixtyDayClose":25.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMVT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-06","symbol":"IMVT","fiscalQuarterEnding":"2025/12","expectedEps":-0.72,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1770354000000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2025-11-10","symbol":"IMVT","fiscalQuarterEnding":"2025/09","expectedEps":-0.72,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.73},{"market":"US","date":"2025-08-11","symbol":"IMVT","fiscalQuarterEnding":"2025/06","expectedEps":-0.69,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2025-05-29","symbol":"IMVT","fiscalQuarterEnding":"2025/03","expectedEps":-0.72,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1748491200000,"reportTimeType":"pre","actualEps":-0.64},{"market":"US","date":"2025-02-06","symbol":"IMVT","fiscalQuarterEnding":"2024/12","expectedEps":-0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":-0.76}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMVT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMVT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.3333,"hold":0.2778,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":18,"updateTime":1773979200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMVT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMVT","date":"2026-03-25","current":-9.46299,"percent":0.479475,"low":-25.043723,"twenty":-15.35755,"median":-10.089767,"eighty":-6.460485,"high":-2.512527,"avg":-10.845113,"sd":5.105683,"marketCap":4852207171},"quantilePoints":[{"date":"2021-03-26","current":-15.349718,"twenty":-50.218345,"median":-29.652683,"eighty":-16.682513,"marketCap":1532270240},{"date":"2021-04-01","current":-16.53726,"twenty":-50.094501,"median":-29.465607,"eighty":-16.543148,"marketCap":1650815444},{"date":"2021-04-09","current":-15.388975,"twenty":-49.992093,"median":-29.294752,"eighty":-16.434792,"marketCap":1536189090},{"date":"2021-04-16","current":-15.133801,"twenty":-49.963513,"median":-29.10734,"eighty":-16.34686,"marketCap":1510716567},{"date":"2021-04-23","current":-15.15343,"twenty":-49.911118,"median":-28.943355,"eighty":-16.225162,"marketCap":1512675991},{"date":"2021-04-30","current":-15.388975,"twenty":-49.803947,"median":-28.598447,"eighty":-16.026911,"marketCap":1536189090},{"date":"2021-05-07","current":-16.44893,"twenty":-49.722973,"median":-28.507039,"eighty":-16.026911,"marketCap":1641998032},{"date":"2021-05-14","current":-15.212316,"twenty":-49.632472,"median":-28.158569,"eighty":-15.946433,"marketCap":1518554266},{"date":"2021-05-21","current":-15.074915,"twenty":-49.201601,"median":-27.678275,"eighty":-15.74082,"marketCap":1504838292},{"date":"2021-05-28","current":-14.878627,"twenty":-48.634948,"median":-27.106133,"eighty":-15.631207,"marketCap":1485244043},{"date":"2021-06-04","current":-9.056125,"twenty":-48.333665,"median":-26.600712,"eighty":-15.604892,"marketCap":972908581},{"date":"2021-06-11","current":-9.767482,"twenty":-48.168568,"median":-24.80859,"eighty":-15.488103,"marketCap":1049330403},{"date":"2021-06-18","current":-10.241721,"twenty":-48.089197,"median":-23.713404,"eighty":-15.392901,"marketCap":1100278284},{"date":"2021-06-25","current":-10.40588,"twenty":-47.881998,"median":-22.899336,"eighty":-15.349718,"marketCap":1117914089},{"date":"2021-07-02","current":-10.050201,"twenty":-47.398665,"median":-22.325388,"eighty":-15.261198,"marketCap":1079703178},{"date":"2021-07-09","current":-9.913402,"twenty":-46.860554,"median":-22.266822,"eighty":-15.212316,"marketCap":1065006674},{"date":"2021-07-16","current":-9.247644,"twenty":-46.298237,"median":-22.126264,"eighty":-15.181202,"marketCap":993483687},{"date":"2021-07-23","current":-9.110845,"twenty":-46.174394,"median":-22.020844,"eighty":-15.12595,"marketCap":978787183},{"date":"2021-07-30","current":-9.539483,"twenty":-46.036261,"median":-21.798294,"eighty":-15.051361,"marketCap":1024836229},{"date":"2021-08-06","current":-8.295941,"twenty":-45.905273,"median":-21.757297,"eighty":-14.989565,"marketCap":891241250},{"date":"2021-08-13","current":-8.14964,"twenty":-45.759995,"median":-21.564029,"eighty":-14.855073,"marketCap":906191103},{"date":"2021-08-20","current":-8.118614,"twenty":-45.674381,"median":-20.190075,"eighty":-14.772377,"marketCap":902741137},{"date":"2021-08-27","current":-8.687434,"twenty":-45.350855,"median":-18.617912,"eighty":-14.58808,"marketCap":965990516},{"date":"2021-09-03","current":-9.318307,"twenty":-45.181268,"median":-18.361964,"eighty":-14.335036,"marketCap":1036139827},{"date":"2021-09-10","current":-8.914962,"twenty":-44.809739,"median":-18.275807,"eighty":-14.085058,"marketCap":991290268},{"date":"2021-09-17","current":-9.121806,"twenty":-44.702567,"median":-17.754245,"eighty":-13.347933,"marketCap":1014290042},{"date":"2021-09-24","current":-8.945988,"twenty":-44.21434,"median":-17.532713,"eighty":-11.813917,"marketCap":994740234},{"date":"2021-10-01","current":-9.132148,"twenty":-43.847864,"median":-17.306554,"eighty":-10.648463,"marketCap":1015440030},{"date":"2021-10-08","current":-9.328649,"twenty":-43.761836,"median":-17.2904,"eighty":-10.241721,"marketCap":1037289816},{"date":"2021-10-15","current":-9.018384,"twenty":-43.404597,"median":-17.19886,"eighty":-10.050201,"marketCap":1002790155},{"date":"2021-10-22","current":-8.584012,"twenty":-43.297425,"median":-17.18809,"eighty":-9.913402,"marketCap":954490629},{"date":"2021-10-29","current":-8.315115,"twenty":-43.225977,"median":-17.091165,"eighty":-9.813082,"marketCap":924590922},{"date":"2021-11-05","current":-7.702112,"twenty":-43.214069,"median":-17.031932,"eighty":-9.767482,"marketCap":986702110},{"date":"2021-11-12","current":-7.675181,"twenty":-42.868738,"median":-17.005009,"eighty":-9.685403,"marketCap":983252103},{"date":"2021-11-19","current":-7.378946,"twenty":-42.582946,"median":-16.961931,"eighty":-9.61823,"marketCap":945302022},{"date":"2021-11-26","current":-6.974989,"twenty":-42.459103,"median":-16.908084,"eighty":-9.538685,"marketCap":893551911},{"date":"2021-12-03","current":-6.822383,"twenty":-42.008981,"median":-16.854236,"eighty":-9.353465,"marketCap":874001869},{"date":"2021-12-10","current":-6.885221,"twenty":-41.82798,"median":-16.811158,"eighty":-9.315118,"marketCap":882051886},{"date":"2021-12-17","current":-7.055781,"twenty":-41.627925,"median":-16.76808,"eighty":-9.27487,"marketCap":903901933},{"date":"2021-12-23","current":-7.145549,"twenty":-41.396911,"median":-16.69429,"eighty":-9.25281,"marketCap":915401958},{"date":"2021-12-31","current":-7.648251,"twenty":-40.630037,"median":-16.669755,"eighty":-9.186497,"marketCap":979802095},{"date":"2022-01-07","current":-7.172479,"twenty":-39.344724,"median":-16.53726,"eighty":-9.128011,"marketCap":918851965},{"date":"2022-01-14","current":-7.055781,"twenty":-38.554293,"median":-16.467312,"eighty":-9.12107,"marketCap":903901933},{"date":"2022-01-21","current":-5.897771,"twenty":-38.40363,"median":-16.432241,"eighty":-9.0926,"marketCap":755551616},{"date":"2022-01-28","current":-6.032423,"twenty":-38.348239,"median":-16.36616,"eighty":-9.026658,"marketCap":772801653},{"date":"2022-02-04","current":-4.995017,"twenty":-38.013678,"median":-16.318702,"eighty":-8.97937,"marketCap":687898746},{"date":"2022-02-11","current":-4.614686,"twenty":-37.408809,"median":-16.252642,"eighty":-8.927372,"marketCap":635520669},{"date":"2022-02-18","current":-4.640041,"twenty":-37.041014,"median":-16.145556,"eighty":-8.831676,"marketCap":639012541},{"date":"2022-02-25","current":-4.809077,"twenty":-36.795077,"median":-16.09641,"eighty":-8.782582,"marketCap":662291686},{"date":"2022-03-04","current":-4.640041,"twenty":-36.006311,"median":-16.04654,"eighty":-8.697776,"marketCap":639012541},{"date":"2022-03-11","current":-4.344228,"twenty":-35.374855,"median":-15.982664,"eighty":-8.610901,"marketCap":598274036},{"date":"2022-03-18","current":-5.214764,"twenty":-34.291245,"median":-15.928767,"eighty":-8.507299,"marketCap":718161635},{"date":"2022-03-25","current":-4.707656,"twenty":-33.719179,"median":-15.76683,"eighty":-8.393716,"marketCap":648324199},{"date":"2022-04-01","current":-4.724559,"twenty":-33.285538,"median":-15.66888,"eighty":-8.315562,"marketCap":650652113},{"date":"2022-04-08","current":-4.25971,"twenty":-33.162882,"median":-15.630425,"eighty":-8.124819,"marketCap":586634464},{"date":"2022-04-14","current":-4.225903,"twenty":-33.101803,"median":-15.612253,"eighty":-8.061184,"marketCap":581978635},{"date":"2022-04-22","current":-4.006156,"twenty":-32.918988,"median":-15.585263,"eighty":-7.878468,"marketCap":551715745},{"date":"2022-04-29","current":-3.896282,"twenty":-32.808716,"median":-15.488349,"eighty":-7.702112,"marketCap":536584301},{"date":"2022-05-06","current":-3.693439,"twenty":-32.773576,"median":-15.447862,"eighty":-7.58082,"marketCap":508649326},{"date":"2022-05-13","current":-3.414529,"twenty":-32.63867,"median":-15.388975,"eighty":-7.378946,"marketCap":470238737},{"date":"2022-05-20","current":-3.296204,"twenty":-32.363614,"median":-15.349718,"eighty":-7.253271,"marketCap":453943335},{"date":"2022-05-27","current":-3.566662,"twenty":-32.05907,"median":-15.325182,"eighty":-7.172479,"marketCap":491189967},{"date":"2022-06-03","current":-3.828668,"twenty":-31.749841,"median":-15.266058,"eighty":-7.127595,"marketCap":527272643},{"date":"2022-06-10","current":-2.51996,"twenty":-31.597179,"median":-15.212316,"eighty":-7.086302,"marketCap":394953346},{"date":"2022-06-17","current":-2.66863,"twenty":-31.500339,"median":-15.197595,"eighty":-7.055781,"marketCap":418254429},{"date":"2022-06-24","current":-3.099774,"twenty":-31.415025,"median":-15.181828,"eighty":-7.016282,"marketCap":485827568},{"date":"2022-07-01","current":-2.958817,"twenty":-31.329244,"median":-15.1509,"eighty":-6.958831,"marketCap":463735335},{"date":"2022-07-08","current":-3.181843,"twenty":-31.276443,"median":-15.123987,"eighty":-6.879835,"marketCap":498690260},{"date":"2022-07-15","current":-3.226448,"twenty":-31.213945,"median":-15.08473,"eighty":-6.825974,"marketCap":505681245},{"date":"2022-07-22","current":-3.323093,"twenty":-31.171271,"median":-15.016028,"eighty":-6.651823,"marketCap":520828379},{"date":"2022-07-29","current":-3.062896,"twenty":-31.159083,"median":-14.994034,"eighty":-6.274797,"marketCap":480047633},{"date":"2022-08-05","current":-3.330137,"twenty":-31.116441,"median":-14.947328,"eighty":-6.132963,"marketCap":554907357},{"date":"2022-08-12","current":-3.9318,"twenty":-31.059776,"median":-14.844276,"eighty":-5.933678,"marketCap":655163729},{"date":"2022-08-19","current":-4.344569,"twenty":-31.043884,"median":-14.772377,"eighty":-5.24519,"marketCap":723944262},{"date":"2022-08-26","current":-4.148679,"twenty":-31.024067,"median":-14.727064,"eighty":-4.974733,"marketCap":691302653},{"date":"2022-09-02","current":-3.791878,"twenty":-30.998206,"median":-14.57438,"eighty":-4.880072,"marketCap":631848293},{"date":"2022-09-09","current":-3.498043,"twenty":-30.968748,"median":-14.463581,"eighty":-4.812458,"marketCap":582885880},{"date":"2022-09-16","current":-3.41409,"twenty":-30.924945,"median":-14.253038,"eighty":-4.760056,"marketCap":568896618},{"date":"2022-09-23","current":-3.41409,"twenty":-30.740154,"median":-14.085058,"eighty":-4.717797,"marketCap":568896618},{"date":"2022-09-30","current":-3.903816,"twenty":-30.652064,"median":-13.55906,"eighty":-4.658635,"marketCap":650500642},{"date":"2022-10-07","current":-7.041334,"twenty":-30.499874,"median":-13.259251,"eighty":-4.658635,"marketCap":1173311529},{"date":"2022-10-14","current":-7.118796,"twenty":-30.471738,"median":-12.316954,"eighty":-4.673849,"marketCap":1186219247},{"date":"2022-10-21","current":-7.83145,"twenty":-30.437961,"median":-10.997103,"eighty":-4.709346,"marketCap":1304970249},{"date":"2022-10-28","current":-8.567343,"twenty":-30.366522,"median":-10.527171,"eighty":-4.716107,"marketCap":1427593566},{"date":"2022-11-04","current":-8.801735,"twenty":-30.327635,"median":-10.259961,"eighty":-4.717797,"marketCap":1556648534},{"date":"2022-11-11","current":-8.874779,"twenty":-30.262829,"median":-10.136841,"eighty":-4.726249,"marketCap":1569566779},{"date":"2022-11-18","current":-9.641735,"twenty":-30.212629,"median":-10.050201,"eighty":-4.733011,"marketCap":1705208353},{"date":"2022-11-25","current":-9.656344,"twenty":-30.056111,"median":-10.031961,"eighty":-4.733011,"marketCap":1707792002},{"date":"2022-12-02","current":-10.722778,"twenty":-30.030502,"median":-9.981801,"eighty":-4.758366,"marketCap":1896398380},{"date":"2022-12-09","current":-10.576691,"twenty":-30.020971,"median":-10.050201,"eighty":-4.766818,"marketCap":1870561890},{"date":"2022-12-16","current":-11.621213,"twenty":-29.868699,"median":-10.122584,"eighty":-4.77527,"marketCap":2055292795},{"date":"2022-12-23","current":-11.854952,"twenty":-29.847686,"median":-10.241721,"eighty":-4.783722,"marketCap":2096631179},{"date":"2022-12-30","current":-12.965212,"twenty":-29.836375,"median":-10.3694,"eighty":-4.804006,"marketCap":2292988505},{"date":"2023-01-06","current":-14.404168,"twenty":-29.825173,"median":-10.489039,"eighty":-4.819219,"marketCap":2547477933},{"date":"2023-01-13","current":-13.586081,"twenty":-29.81451,"median":-10.612577,"eighty":-4.831052,"marketCap":2402793588},{"date":"2023-01-20","current":-12.892169,"twenty":-29.786748,"median":-10.700865,"eighty":-4.851337,"marketCap":2280070260},{"date":"2023-01-27","current":-12.943299,"twenty":-29.720934,"median":-10.766604,"eighty":-4.880072,"marketCap":2289113031},{"date":"2023-02-03","current":-11.546961,"twenty":-29.677058,"median":-10.982162,"eighty":-4.895285,"marketCap":2294369508},{"date":"2023-02-10","current":-11.989323,"twenty":-29.667308,"median":-11.109908,"eighty":-4.927403,"marketCap":2382266481},{"date":"2023-02-17","current":-11.930775,"twenty":-29.652683,"median":-11.481216,"eighty":-4.956139,"marketCap":2370633058},{"date":"2023-02-24","current":-11.137125,"twenty":-29.618557,"median":-11.546961,"eighty":-4.967971,"marketCap":2212935548},{"date":"2023-03-03","current":-11.072071,"twenty":-29.475476,"median":-11.384327,"eighty":-4.998398,"marketCap":2200009523},{"date":"2023-03-10","current":-10.115788,"twenty":-29.44669,"median":-11.293252,"eighty":-5.027134,"marketCap":2009996949},{"date":"2023-03-17","current":-10.083261,"twenty":-29.4084,"median":-11.109908,"eighty":-5.113342,"marketCap":2003533937},{"date":"2023-03-24","current":-9.933639,"twenty":-29.294752,"median":-11.028047,"eighty":-5.229977,"marketCap":1973804078},{"date":"2023-03-31","current":-10.089767,"twenty":-29.273668,"median":-10.96722,"eighty":-5.313473,"marketCap":2004826539},{"date":"2023-04-06","current":-9.341654,"twenty":-29.189333,"median":-10.941965,"eighty":-5.404046,"marketCap":1856177247},{"date":"2023-04-14","current":-9.992187,"twenty":-29.025348,"median":-10.824869,"eighty":-5.861863,"marketCap":1985437501},{"date":"2023-04-21","current":-9.901112,"twenty":-29.004644,"median":-10.737387,"eighty":-5.897771,"marketCap":1967341065},{"date":"2023-04-28","current":-10.454065,"twenty":-28.943355,"median":-10.663708,"eighty":-5.987539,"marketCap":2077212281},{"date":"2023-05-05","current":-12.360127,"twenty":-28.848295,"median":-10.722778,"eighty":-6.005493,"marketCap":2455944826},{"date":"2023-05-12","current":-11.891743,"twenty":-28.616728,"median":-10.776221,"eighty":-6.032423,"marketCap":2362877443},{"date":"2023-05-19","current":-13.810815,"twenty":-28.580165,"median":-10.934604,"eighty":-6.06833,"marketCap":2744195192},{"date":"2023-05-26","current":-13.024767,"twenty":-28.568532,"median":-10.96435,"eighty":-6.229913,"marketCap":2747704756},{"date":"2023-06-02","current":-12.783682,"twenty":-28.519338,"median":-11.011819,"eighty":-6.258639,"marketCap":2696845484},{"date":"2023-06-09","current":-13.136037,"twenty":-28.455851,"median":-11.050816,"eighty":-6.271206,"marketCap":2771178266},{"date":"2023-06-16","current":-13.061857,"twenty":-28.284915,"median":-11.137125,"eighty":-6.274797,"marketCap":2755529259},{"date":"2023-06-23","current":-12.672412,"twenty":-28.165597,"median":-11.364811,"eighty":-6.274797,"marketCap":2673371974},{"date":"2023-06-30","current":-11.461991,"twenty":-28.12343,"median":-11.374944,"eighty":-6.274797,"marketCap":2418021685},{"date":"2023-07-07","current":-11.814763,"twenty":-28.119591,"median":-11.415471,"eighty":-6.307127,"marketCap":2492442439},{"date":"2023-07-14","current":-12.545063,"twenty":-27.853778,"median":-11.471474,"eighty":-6.339439,"marketCap":2646506456},{"date":"2023-07-21","current":-14.25941,"twenty":-27.605149,"median":-11.546961,"eighty":-6.470492,"marketCap":3008165207},{"date":"2023-07-28","current":-13.448654,"twenty":-27.503496,"median":-11.621213,"eighty":-6.563851,"marketCap":2837128035},{"date":"2023-08-04","current":-13.83856,"twenty":-27.169736,"median":-11.648488,"eighty":-6.651823,"marketCap":2919382553},{"date":"2023-08-11","current":-11.927629,"twenty":-26.717844,"median":-11.677067,"eighty":-6.766727,"marketCap":2916591607},{"date":"2023-08-18","current":-10.468739,"twenty":-26.603055,"median":-11.648488,"eighty":-6.795453,"marketCap":2559857956},{"date":"2023-08-25","current":-10.693184,"twenty":-25.886206,"median":-11.621213,"eighty":-6.822383,"marketCap":2614740056},{"date":"2023-09-01","current":-12.136042,"twenty":-24.822646,"median":-11.629624,"eighty":-6.825974,"marketCap":2967553557},{"date":"2023-09-08","current":-12.291016,"twenty":-24.80859,"median":-11.643126,"eighty":-6.83136,"marketCap":3005448341},{"date":"2023-09-15","current":-11.761968,"twenty":-23.955868,"median":-11.65385,"eighty":-6.860086,"marketCap":2876083390},{"date":"2023-09-22","current":-11.35583,"twenty":-23.728631,"median":-11.65385,"eighty":-6.867267,"marketCap":2776772923},{"date":"2023-09-29","current":-21.263457,"twenty":-23.714576,"median":-11.65385,"eighty":-6.870858,"marketCap":5199425629},{"date":"2023-10-06","current":-19.680925,"twenty":-23.653667,"median":-11.660433,"eighty":-6.878039,"marketCap":4812458598},{"date":"2023-10-13","current":-20.834252,"twenty":-23.438144,"median":-11.72456,"eighty":-6.885221,"marketCap":5094474618},{"date":"2023-10-17","current":-22.292886,"twenty":-23.222621,"median":-11.748626,"eighty":-6.895993,"marketCap":5451145602},{"date":"2023-10-27","current":-20.225996,"twenty":-23.007098,"median":-11.761968,"eighty":-6.906765,"marketCap":4945741374},{"date":"2023-11-03","current":-19.540969,"twenty":-22.721295,"median":-11.773651,"eighty":-6.940877,"marketCap":4778235972},{"date":"2023-11-10","current":-17.744263,"twenty":-22.44252,"median":-11.813679,"eighty":-6.962421,"marketCap":4529365028},{"date":"2023-11-17","current":-19.110078,"twenty":-22.3111,"median":-11.817473,"eighty":-6.973194,"marketCap":4878000279},{"date":"2023-11-24","current":-18.940059,"twenty":-22.277248,"median":-11.85033,"eighty":-6.985761,"marketCap":4834601700},{"date":"2023-12-01","current":-22.176078,"twenty":-22.266822,"median":-11.913787,"eighty":-7.003715,"marketCap":5660621320},{"date":"2023-12-08","current":-22.822148,"twenty":-22.482157,"median":-11.931874,"eighty":-7.016282,"marketCap":5825535921},{"date":"2023-12-15","current":-24.131291,"twenty":-22.73493,"median":-11.976312,"eighty":-7.030645,"marketCap":6159704979},{"date":"2023-12-22","current":-22.159076,"twenty":-22.931934,"median":-12.00411,"eighty":-7.039931,"marketCap":5656281463},{"date":"2023-12-29","current":-24.000943,"twenty":-23.309535,"median":-12.068511,"eighty":-7.044223,"marketCap":6126432735},{"date":"2024-01-05","current":-22.040063,"twenty":-23.371527,"median":-12.086903,"eighty":-7.052892,"marketCap":5625902457},{"date":"2024-01-12","current":-24.295642,"twenty":-23.561422,"median":-12.138946,"eighty":-7.055781,"marketCap":6201656939},{"date":"2024-01-19","current":-22.975165,"twenty":-23.712233,"median":-12.223515,"eighty":-7.055781,"marketCap":5864594642},{"date":"2024-01-26","current":-21.67169,"twenty":-23.597954,"median":-12.290083,"eighty":-7.057663,"marketCap":5531872203},{"date":"2024-02-02","current":-20.441889,"twenty":-23.51469,"median":-12.301704,"eighty":-7.062421,"marketCap":5217955815},{"date":"2024-02-09","current":-19.988507,"twenty":-23.477286,"median":-12.36338,"eighty":-7.080916,"marketCap":5102226271},{"date":"2024-02-16","current":-22.559445,"twenty":-23.44564,"median":-12.437508,"eighty":-7.097074,"marketCap":5492074266},{"date":"2024-02-23","current":-21.479217,"twenty":-23.404836,"median":-12.462021,"eighty":-7.107846,"marketCap":5229093990},{"date":"2024-03-01","current":-21.109195,"twenty":-23.2982,"median":-12.528508,"eighty":-7.118689,"marketCap":5139012348},{"date":"2024-03-08","current":-19.360539,"twenty":-23.179187,"median":-12.568297,"eighty":-7.122316,"marketCap":4713303946},{"date":"2024-03-15","current":-18.322089,"twenty":-23.069242,"median":-12.654464,"eighty":-7.127595,"marketCap":4460494179},{"date":"2024-03-22","current":-19.748466,"twenty":-22.978565,"median":-12.767995,"eighty":-7.134777,"marketCap":4807744377},{"date":"2024-03-28","current":-19.408284,"twenty":-22.959999,"median":-12.783682,"eighty":-7.147344,"marketCap":4724927384},{"date":"2024-04-05","current":-18.405642,"twenty":-22.898201,"median":-12.828005,"eighty":-7.155126,"marketCap":4480835194},{"date":"2024-04-12","current":-18.334025,"twenty":-22.890691,"median":-12.855647,"eighty":-7.159076,"marketCap":4463400038},{"date":"2024-04-19","current":-16.901679,"twenty":-22.867486,"median":-12.888517,"eighty":-7.166715,"marketCap":4114696910},{"date":"2024-04-26","current":-16.561497,"twenty":-22.811384,"median":-12.965212,"eighty":-7.172479,"marketCap":4031879917},{"date":"2024-05-03","current":-17.176212,"twenty":-22.753023,"median":-12.983749,"eighty":-7.177865,"marketCap":4181531676},{"date":"2024-05-10","current":-17.725278,"twenty":-22.688798,"median":-13.001734,"eighty":-7.19941,"marketCap":4315201209},{"date":"2024-05-17","current":-18.787601,"twenty":-22.66732,"median":-13.018585,"eighty":-7.200329,"marketCap":4573822695},{"date":"2024-05-24","current":-16.943456,"twenty":-22.615458,"median":-13.105128,"eighty":-7.205554,"marketCap":4124867418},{"date":"2024-05-31","current":-14.873695,"twenty":-22.559445,"median":-13.140516,"eighty":-7.211751,"marketCap":3857284581},{"date":"2024-06-07","current":-14.321775,"twenty":-22.559445,"median":-13.179296,"eighty":-7.23499,"marketCap":3714151719},{"date":"2024-06-14","current":-14.9807,"twenty":-22.54745,"median":-13.27658,"eighty":-7.241187,"marketCap":3885034830},{"date":"2024-06-21","current":-15.369297,"twenty":-22.503315,"median":-13.348781,"eighty":-7.249057,"marketCap":3985812049},{"date":"2024-06-28","current":-14.655441,"twenty":-22.475891,"median":-13.354639,"eighty":-7.253271,"marketCap":3800683484},{"date":"2024-07-05","current":-14.768175,"twenty":-22.402341,"median":-13.397904,"eighty":-7.281997,"marketCap":3829919510},{"date":"2024-07-12","current":-17.101772,"twenty":-22.381112,"median":-13.461032,"eighty":-7.332267,"marketCap":4435105265},{"date":"2024-07-15","current":-17.231417,"twenty":-22.380402,"median":-13.465439,"eighty":-7.343039,"marketCap":4468726696},{"date":"2024-08-02","current":-16.273176,"twenty":-22.365607,"median":-13.469846,"eighty":-7.344668,"marketCap":4220220468},{"date":"2024-08-09","current":-15.101323,"twenty":-22.303718,"median":-13.49843,"eighty":-7.353145,"marketCap":4115850556},{"date":"2024-08-16","current":-16.58353,"twenty":-22.29106,"median":-13.553867,"eighty":-7.364583,"marketCap":4519824509},{"date":"2024-08-23","current":-16.862786,"twenty":-22.280369,"median":-13.606531,"eighty":-7.38114,"marketCap":4595935543},{"date":"2024-08-30","current":-16.637233,"twenty":-22.266822,"median":-13.695647,"eighty":-7.402309,"marketCap":4534461246},{"date":"2024-09-06","current":-18.054996,"twenty":-22.266822,"median":-13.730342,"eighty":-7.451885,"marketCap":4920871113},{"date":"2024-09-13","current":-15.498727,"twenty":-22.266822,"median":-13.799931,"eighty":-7.503813,"marketCap":4224162413},{"date":"2024-09-20","current":-15.890759,"twenty":-22.243396,"median":-13.83856,"eighty":-7.504622,"marketCap":4331010596},{"date":"2024-09-27","current":-15.203359,"twenty":-22.210082,"median":-14.00597,"eighty":-7.522575,"marketCap":4143660357},{"date":"2024-10-04","current":-15.72428,"twenty":-22.176078,"median":-14.129442,"eighty":-7.58082,"marketCap":4285636710},{"date":"2024-10-11","current":-16.07335,"twenty":-22.159582,"median":-14.173668,"eighty":-7.603367,"marketCap":4380775503},{"date":"2024-10-18","current":-15.713539,"twenty":-22.159076,"median":-14.209138,"eighty":-7.606809,"marketCap":4282709363},{"date":"2024-10-25","current":-16.379458,"twenty":-22.126264,"median":-14.288612,"eighty":-7.648251,"marketCap":4464204907},{"date":"2024-10-31","current":-16.207608,"twenty":-22.116243,"median":-14.312811,"eighty":-7.658477,"marketCap":4417367347},{"date":"2024-11-08","current":-13.562521,"twenty":-22.096429,"median":-14.321775,"eighty":-7.672351,"marketCap":4380775503},{"date":"2024-11-15","current":-12.74685,"twenty":-22.09132,"median":-14.304879,"eighty":-7.696726,"marketCap":4117309123},{"date":"2024-11-22","current":-12.060656,"twenty":-22.083822,"median":-14.25941,"eighty":-7.745732,"marketCap":3895664319},{"date":"2024-11-29","current":-12.815015,"twenty":-22.066389,"median":-14.192242,"eighty":-7.783169,"marketCap":4139326819},{"date":"2024-12-06","current":-12.905902,"twenty":-22.046431,"median":-14.16152,"eighty":-7.819213,"marketCap":4168683747},{"date":"2024-12-13","current":-12.537811,"twenty":-22.036576,"median":-14.129442,"eighty":-7.856183,"marketCap":4049788190},{"date":"2024-12-20","current":-11.660755,"twenty":-22.024542,"median":-13.936075,"eighty":-7.87383,"marketCap":3766493836},{"date":"2024-12-27","current":-11.692565,"twenty":-22.024542,"median":-13.813461,"eighty":-7.87383,"marketCap":3776768761},{"date":"2025-01-03","current":-11.447171,"twenty":-22.024542,"median":-13.712995,"eighty":-7.87383,"marketCap":3697505056},{"date":"2025-01-10","current":-10.738256,"twenty":-22.034251,"median":-13.586081,"eighty":-7.872671,"marketCap":3468521019},{"date":"2025-01-17","current":-10.815509,"twenty":-22.034251,"median":-13.505734,"eighty":-7.872671,"marketCap":3493474408},{"date":"2025-01-24","current":-10.633736,"twenty":-22.034251,"median":-13.461032,"eighty":-7.872671,"marketCap":3434760552},{"date":"2025-01-31","current":-11.604101,"twenty":-22.034251,"median":-13.34963,"eighty":-7.872671,"marketCap":3748194358},{"date":"2025-02-07","current":-9.034991,"twenty":-22.034251,"median":-13.191647,"eighty":-7.872671,"marketCap":3457781474},{"date":"2025-02-14","current":-8.814594,"twenty":-22.034251,"median":-13.136037,"eighty":-7.872671,"marketCap":3373433164},{"date":"2025-02-21","current":-9.076457,"twenty":-22.034251,"median":-13.083131,"eighty":-7.872671,"marketCap":3473650967},{"date":"2025-02-28","current":-8.98769,"twenty":-22.034251,"median":-13.006222,"eighty":-7.872671,"marketCap":3439678830},{"date":"2025-03-07","current":-8.663689,"twenty":-22.035413,"median":-12.974476,"eighty":-7.864427,"marketCap":3315680532},{"date":"2025-03-14","current":-8.339689,"twenty":-22.035413,"median":-12.899036,"eighty":-7.864427,"marketCap":3191682233},{"date":"2025-03-21","current":-8.739142,"twenty":-22.035413,"median":-12.899036,"eighty":-7.864427,"marketCap":3344556848},{"date":"2025-03-28","current":-8.339689,"twenty":-22.035413,"median":-12.888517,"eighty":-7.864427,"marketCap":3191682233},{"date":"2025-04-04","current":-7.003741,"twenty":-22.035413,"median":-12.830025,"eighty":-7.696726,"marketCap":2680401577},{"date":"2025-04-11","current":-6.564342,"twenty":-22.034251,"median":-12.783682,"eighty":-7.603367,"marketCap":2512239501},{"date":"2025-04-17","current":-6.586534,"twenty":-21.985705,"median":-12.716864,"eighty":-7.504622,"marketCap":2520732535},{"date":"2025-04-25","current":-6.688617,"twenty":-21.964158,"median":-12.562143,"eighty":-7.35903,"marketCap":2559800492},{"date":"2025-05-02","current":-7.057001,"twenty":-21.911141,"median":-12.506497,"eighty":-7.251164,"marketCap":2700784859},{"date":"2025-05-09","current":-6.346863,"twenty":-21.67169,"median":-12.392798,"eighty":-7.19941,"marketCap":2429007766},{"date":"2025-05-16","current":-6.178205,"twenty":-21.209202,"median":-12.29651,"eighty":-7.163725,"marketCap":2364460707},{"date":"2025-05-23","current":-6.46226,"twenty":-20.880885,"median":-12.221612,"eighty":-7.125835,"marketCap":2473171544},{"date":"2025-05-30","current":-6.149832,"twenty":-20.66213,"median":-12.137494,"eighty":-7.086302,"marketCap":2545046313},{"date":"2025-06-06","current":-6.616541,"twenty":-20.434526,"median":-12.064584,"eighty":-7.055781,"marketCap":2738189519},{"date":"2025-06-13","current":-6.5835,"twenty":-20.103163,"median":-11.976312,"eighty":-7.012273,"marketCap":2724515664},{"date":"2025-06-20","current":-6.550459,"twenty":-19.804887,"median":-11.928871,"eighty":-6.971398,"marketCap":2710841809},{"date":"2025-06-27","current":-6.769358,"twenty":-19.70078,"median":-11.854952,"eighty":-6.901379,"marketCap":2801431100},{"date":"2025-07-03","current":-7.000648,"twenty":-19.421201,"median":-11.835447,"eighty":-6.867267,"marketCap":2897148087},{"date":"2025-07-11","current":-7.233981,"twenty":-19.186973,"median":-11.777611,"eighty":-6.865933,"marketCap":2993710580},{"date":"2025-07-18","current":-7.55641,"twenty":-18.997537,"median":-11.751642,"eighty":-6.865933,"marketCap":3127144537},{"date":"2025-07-25","current":-7.572944,"twenty":-18.874693,"median":-11.660755,"eighty":-6.865933,"marketCap":3133987304},{"date":"2025-08-01","current":-6.646995,"twenty":-18.787601,"median":-11.638035,"eighty":-6.857718,"marketCap":2750792350},{"date":"2025-08-08","current":-6.502315,"twenty":-18.6123,"median":-11.58307,"eighty":-6.822383,"marketCap":2690918138},{"date":"2025-08-15","current":-5.923537,"twenty":-18.472551,"median":-11.462391,"eighty":-6.757804,"marketCap":2649615983},{"date":"2025-08-22","current":-5.783243,"twenty":-18.348349,"median":-11.430592,"eighty":-6.709921,"marketCap":2586861920},{"date":"2025-08-29","current":-5.775449,"twenty":-18.24245,"median":-11.35583,"eighty":-6.650511,"marketCap":2583375583},{"date":"2025-09-05","current":-6.282067,"twenty":-18.119173,"median":-11.209464,"eighty":-6.610234,"marketCap":2809987476},{"date":"2025-09-12","current":-6.547067,"twenty":-17.789734,"median":-11.129068,"eighty":-6.58532,"marketCap":2928522928},{"date":"2025-09-19","current":-6.001479,"twenty":-17.675146,"median":-11.029561,"eighty":-6.549102,"marketCap":2684479351},{"date":"2025-09-26","current":-6.106699,"twenty":-17.419151,"median":-10.992443,"eighty":-6.512551,"marketCap":2731544898},{"date":"2025-10-03","current":-6.519788,"twenty":-17.189039,"median":-10.936353,"eighty":-6.484884,"marketCap":2916320749},{"date":"2025-10-10","current":-6.812068,"twenty":-17.085561,"median":-10.842775,"eighty":-6.460485,"marketCap":3047058380},{"date":"2025-10-17","current":-6.784788,"twenty":-16.950618,"median":-10.766604,"eighty":-6.460485,"marketCap":3034856201},{"date":"2025-10-24","current":-7.303098,"twenty":-16.867082,"median":-10.719903,"eighty":-6.460485,"marketCap":3266697600},{"date":"2025-10-31","current":-9.672513,"twenty":-16.739971,"median":-10.576691,"eighty":-6.460485,"marketCap":4326543993},{"date":"2025-11-07","current":-9.22435,"twenty":-16.648279,"median":-10.489039,"eighty":-6.460485,"marketCap":4126079626},{"date":"2025-11-14","current":-8.607555,"twenty":-16.552843,"median":-10.454065,"eighty":-6.460485,"marketCap":3999810323},{"date":"2025-11-21","current":-8.596239,"twenty":-16.431264,"median":-10.338355,"eighty":-6.460485,"marketCap":3994552027},{"date":"2025-11-28","current":-9.109222,"twenty":-16.381606,"median":-10.265411,"eighty":-6.460485,"marketCap":4232928102},{"date":"2025-12-05","current":-8.641502,"twenty":-16.331842,"median":-10.219873,"eighty":-6.460485,"marketCap":4015585210},{"date":"2025-12-12","current":-9.35817,"twenty":-16.220844,"median":-10.115788,"eighty":-6.460485,"marketCap":4348610610},{"date":"2025-12-19","current":-11.418716,"twenty":-16.156253,"median":-10.089767,"eighty":-6.460485,"marketCap":5306117291},{"date":"2025-12-26","current":-11.724029,"twenty":-16.088699,"median":-10.089767,"eighty":-6.460485,"marketCap":5447992085},{"date":"2026-01-02","current":-11.087233,"twenty":-16.046515,"median":-10.089767,"eighty":-6.460485,"marketCap":5152081801},{"date":"2026-01-09","current":-11.475417,"twenty":-15.959156,"median":-10.089767,"eighty":-6.460485,"marketCap":5332465467},{"date":"2026-01-16","current":-11.340207,"twenty":-15.898278,"median":-10.089767,"eighty":-6.460485,"marketCap":5269635202},{"date":"2026-01-23","current":-11.418716,"twenty":-15.837056,"median":-10.089767,"eighty":-6.460485,"marketCap":5306117291},{"date":"2026-01-30","current":-11.536479,"twenty":-15.78978,"median":-10.089767,"eighty":-6.460485,"marketCap":5360840426},{"date":"2026-02-06","current":-10.494053,"twenty":-15.717835,"median":-10.089767,"eighty":-6.460485,"marketCap":4876439344},{"date":"2026-02-13","current":-11.242086,"twenty":-15.652572,"median":-10.089767,"eighty":-6.460485,"marketCap":5218565095},{"date":"2026-02-20","current":-11.557776,"twenty":-15.609684,"median":-10.089767,"eighty":-6.460485,"marketCap":5365108264},{"date":"2026-02-27","current":-12.018158,"twenty":-15.585357,"median":-10.089767,"eighty":-6.460485,"marketCap":5578817053},{"date":"2026-03-06","current":-11.715622,"twenty":-15.585357,"median":-10.089767,"eighty":-6.460485,"marketCap":5438379849},{"date":"2026-03-13","current":-10.957088,"twenty":-15.479394,"median":-10.089767,"eighty":-6.460485,"marketCap":5086269178},{"date":"2026-03-20","current":-10.369553,"twenty":-15.388975,"median":-10.089767,"eighty":-6.460485,"marketCap":4813536057},{"date":"2026-03-25","current":-10.45286,"twenty":-15.35755,"median":-10.089767,"eighty":-6.460485,"marketCap":4852207171}],"updateTime":1774565949835},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMVT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2585110032","title":"J.P. Morgan Sticks to Their Buy Rating for Immunovant (IMVT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2585110032","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585110032?lang=en_us&edition=fundamental","pubTime":"2025-11-21 20:18","pubTimestamp":1763727491,"startTime":"0","endTime":"0","summary":"In a report released on November 19, Brian Cheng from J.P. Morgan maintained a Buy rating on Immunovant, with a price target of $34.00. The company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-buy-rating-for-immunovant-imvt-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-buy-rating-for-immunovant-imvt-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMVT"],"gpt_icon":0},{"id":"2583680021","title":"H.C. Wainwright Reaffirms Their Buy Rating on Immunovant (IMVT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583680021","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583680021?lang=en_us&edition=fundamental","pubTime":"2025-11-15 07:37","pubTimestamp":1763163476,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Immunovant today and set a price target of $35.00. According to TipRanks, Tsao is a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-immunovant-imvt-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-immunovant-imvt-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMVT"],"gpt_icon":0},{"id":"2583590279","title":"Immunovant (IMVT): Assessing Valuation After Earnings Beat and Encouraging Graves’ Disease Study Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583590279","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583590279?lang=en_us&edition=fundamental","pubTime":"2025-11-13 22:27","pubTimestamp":1763044064,"startTime":"0","endTime":"0","summary":"Immunovant (IMVT) grabbed investor attention after releasing its latest earnings, reporting a quarterly loss per share that came in better than anticipated. At the same time, updates on key drug studies gave observers plenty to consider.\nSee our latest analysis for Immunovant.\nImmunovant’s 35.1% 1-month share price return stands out, particularly following positive clinical updates and a quarterly loss that beat expectations. Despite this short-term momentum, its total shareholder return over...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imvt/immunovant/news/immunovant-imvt-assessing-valuation-after-earnings-beat-and","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imvt/immunovant/news/immunovant-imvt-assessing-valuation-after-earnings-beat-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IMVT"],"gpt_icon":0},{"id":"1111880053","title":"Stock Track | Immunovant Shares Plummet 8.01% on Q2 Earnings Miss and Clinical Trial Result Delays","url":"https://stock-news.laohu8.com/highlight/detail?id=1111880053","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111880053?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:44","pubTimestamp":1762785867,"startTime":"0","endTime":"0","summary":"Shares of Immunovant, Inc. (IMVT) plummeted 8.01% in Monday's pre-market trading session following the release of its fiscal second-quarter financial results and updates on clinical trial timelines....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IMVT"],"gpt_icon":0},{"id":"1165109008","title":"Stock Track | Immunovant Plummets 8.01% on Q2 Earnings Miss and Delayed Clinical Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1165109008","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165109008?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:44","pubTimestamp":1762785862,"startTime":"0","endTime":"0","summary":"Shares of Immunovant, Inc. (IMVT) plummeted 8.01% in pre-market trading on Monday following the release of its second-quarter financial results and clinical trial updates. The biopharmaceutical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IMVT"],"gpt_icon":0},{"id":"2582587204","title":"Sector Update: Health Care Stocks Mixed Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2582587204","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582587204?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:17","pubTimestamp":1762784228,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Monday, with the Health Care Select Sector SPDR Fund (XLV) down 0.2% and the iShares Biotechnology ETF (IBB) 0.5% higher.Metsera (MTSR) announced late Friday an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0122379950.USD","LU0234572021.USD","LU1066051498.USD","BK4581","BK7104","LU0321505868.SGD","IE00BZ1G4Q59.USD","BK4592","BK4121","LU0225284248.USD","LU0306807586.USD","IBB","LU0058720904.USD","LU1057294990.SGD","LU1093756168.USD","BK4533","BK4534","LU1894683348.USD","NVO","BK4532","MTSR","NVO.AU","BK4599","PFE.AU","LABU","SG9999011175.SGD","SG9999001176.USD","IE00B19Z3B42.SGD","BK7095","IE0002270589.USD","IMVT","LU1093756325.SGD","LU1894683264.USD","LU0456855351.SGD","IE00BKVL7J92.USD","PFE","BK4585","LU0985481810.HKD","SG9999001176.SGD","LU0321505439.SGD","XLV","IE000M9KFDE8.USD","RVTY","IE00BBT3K403.USD","BK4139","LU0868494617.USD","LU0289739699.SGD","SG9999013999.USD","XBI","SG9999003800.SGD"],"gpt_icon":1},{"id":"1135527889","title":"Stock Track | Immunovant Plunges 5.78% Pre-Market on Q2 Earnings Miss and Clinical Trial Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=1135527889","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135527889?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:13","pubTimestamp":1762784016,"startTime":"0","endTime":"0","summary":"Shares of Immunovant, Inc. (IMVT) tumbled 5.78% in pre-market trading on Monday following the release of its second-quarter financial results and clinical trial updates. The biopharmaceutical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IMVT"],"gpt_icon":0},{"id":"2582768138","title":"Immunovant Fiscal Q2 Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2582768138","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582768138?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:32","pubTimestamp":1762777958,"startTime":"0","endTime":"0","summary":"Immunovant  reported a fiscal Q2 net loss Monday of $0.73 per diluted share, narrower than the net loss of $0.74 a year earlier.Analysts polled by FactSet expected a loss of $0.69.As of Sept. 30, the company said it had $521.9 million in cash and cash equivalents, which will likely finance operations through Graves' disease trial readout anticipated in 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMVT","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2582875506","title":"Autoimmune drugmaker Immunovant's Q2 net loss misses estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2582875506","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582875506?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:19","pubTimestamp":1762777165,"startTime":"0","endTime":"0","summary":"Autoimmune drugmaker Immunovant's Q2 net loss misses estimatesOverviewImmunovant Q2 net loss misses analyst expectationsCompany advances IMVT-1402 trials across multiple indications, contributing to i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL1N3WM0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2582753958","title":"Earnings Flash (IMVT) Immunovant Posts Fiscal Q2 Loss $0.73 a Share, vs. FactSet Est of $0.70 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2582753958","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582753958?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:16","pubTimestamp":1762776980,"startTime":"0","endTime":"0","summary":"Earnings Flash (IMVT) Immunovant Posts Fiscal Q2 Loss $0.73 a Share, vs. FactSet Est of $0.70 Loss","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMVT"],"gpt_icon":0},{"id":"2582875586","title":"Biopharma Roivant's Q2 income from operations misses","url":"https://stock-news.laohu8.com/highlight/detail?id=2582875586","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582875586?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:14","pubTimestamp":1762776864,"startTime":"0","endTime":"0","summary":"Biopharma Roivant's Q2 income from operations missesOverviewRoivant Q2 revenue declines, missing analyst expectations for income from operationsCompany maintains strong cash position of $4.4 bln, supp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL1N3WM0D9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ROIV","BK4585","IMVT","BK4007","BK4139"],"gpt_icon":0},{"id":"2582873600","title":"Immunovant Q2 EPS $(0.73) Misses $(0.72) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582873600","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582873600?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:03","pubTimestamp":1762776200,"startTime":"0","endTime":"0","summary":"Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.72) by 0.69 percent. This is a 1.35 percent increase over losses of $(0.74) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48748201/immunovant-q2-eps-0-73-misses-0-72-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","QLD","MNQmain","PSQ","SQQQ","NQmain","TSYW.SI","TQQQ","USAW.SI","NVIW.SI","QID","USJW.SI","BK4139","BK4585","BK4588","IMVT"],"gpt_icon":0},{"id":"2582873916","title":"Immunovant reports cash and cash equivalents of $521.9 million as of September 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2582873916","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582873916?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:03","pubTimestamp":1762776198,"startTime":"0","endTime":"0","summary":"Immunovant Inc. reported cash and cash equivalents of approximately $521.9 million as of September 30, 2025, providing financial runway through expected Graves' disease readout in 2027. The company continues development of IMVT-1402, with potentially registrational studies progressing in Graves' disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, difficult-to-treat rheumatoid arthritis, and Sjgren's disease. Results from the open-label portion of the IMVT-1402 trial in difficult-to-treat rheumatoid arthritis and topline results from the proof-of-concept trial in cutaneous lupus erythematosus are expected in 2026. Topline results from potentially registrational trials in three indications are anticipated in 2027. Immunovant expects to share topline results from both Phase 3 thyroid eye disease studies for batoclimab concurrently in the first half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. W","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDLb5x2hC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IMVT","BK4588","BK4139"],"gpt_icon":0},{"id":"2582873571","title":"Roivant Sciences posts $113.5 million net loss for quarter ended September 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2582873571","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582873571?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:01","pubTimestamp":1762776103,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. reported a net loss attributable to the company of $113.5 million for the three months ended September 30, 2025, compared to a net loss of $230.2 million for the same period in 2024. Basic and diluted net loss per common share was $0.17, down from $0.31 in the prior year period. As of September 30, 2025, Roivant had $1.2 billion in cash, cash equivalents, and restricted cash, and $3.1 billion in marketable securities, supporting a cash runway into profitability. Total assets stood at $5.1 billion, with total liabilities of $257.1 million and total shareholders' equity of $4.8 billion. Recent business developments included positive brepocitinib data in dermatomyositis and Immunovant's remission data in Graves' disease. Roivant announced plans to provide further updates during its investor day in December 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDLb49lcL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","NDAQ","BK4112","LU2210150020.SGD","BK4007","LU0314104364.USD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","ROIV","BK4139","IE00B64PRP62.GBP","BK4585","BK4588","IMVT"],"gpt_icon":0},{"id":"2582696873","title":"BRIEF-Immunovant Q2 Net Income USD -126.502 Million Vs. IBES Estimate USD -124.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582696873","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582696873?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776046,"startTime":"0","endTime":"0","summary":"BRIEF-Immunovant Q2 Net Income USD -126.502 Million Vs. IBES Estimate USD -124.1 Million\n\n\nNov 10 (Reuters) - Immunovant Q2 operating expenses USD 131.762 million.\n\nQ2 basic EPS USD -0.73","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLXE888FB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","IMVT","BK4139"],"gpt_icon":0},{"id":"2582739028","title":"Immunovant Inc: Co Anticipates Sharing Topline Results From Both Ted Studies Concurrently in First Half of Calendar Year 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2582739028","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582739028?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLXE888FB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMVT","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2582624873","title":"Immunovant Inc: on Track for First of Two  Bataclimab Phase 3 Ted Study Readout Before End of Calendar Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2582624873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582624873?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLXE888FB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","BK4588","IMVT"],"gpt_icon":0},{"id":"2582984873","title":"Press Release: Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2582984873","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582984873?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776000,"startTime":"0","endTime":"0","summary":"-- Study in uncontrolled Graves' disease  patients treated for 24 weeks. -- IMVT-1402 development is progressing with potentially registrational. studies in GD, myasthenia gravis , chronic inflammatory demyelinating. year 2025. However, due to evolving competitive dynamics, the Company. Immunovant expects to report results from the open-label portion of the potentially registrational trial of IMVT-1402 in D2T RA and topline results from the proof-of-concept trial of IMVT-1402 in CLE in calendar year 2026. In calendar year 2027, topline results are expected across three indications from the potentially registrational trials of IMVT-1402 in GD, MG and D2T RA. Immunovant remains on track for the first of the two batoclimab Phase 3 TED studies to read out before the end of calendar year 2025. However, due to evolving competitive dynamics, the Company anticipates sharing topline results from both TED studies concurrently in the first half of calendar year 2026.Research and Development Expen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4550","IE00B66KJ199.SGD","IE0031619046.USD","IE00B19Z4B17.USD","LU0170899867.USD","BK4123","MG","BK4585","IE00B7SZL793.SGD","GD","BK4516","IMVT","BK4139","BK4566","BK4187"],"gpt_icon":0},{"id":"2582581756","title":"Immunovant (IMVT) Receives a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2582581756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582581756?lang=en_us&edition=fundamental","pubTime":"2025-11-10 09:15","pubTimestamp":1762737356,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Immunovant, with a price target of $35.00. Tsao covers...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/immunovant-imvt-receives-a-buy-from-h-c-wainwright-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/immunovant-imvt-receives-a-buy-from-h-c-wainwright-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMVT","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2581853479","title":"Immunovant CEO Eric Venker Reports Disposal of Roivant Sciences Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2581853479","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581853479?lang=en_us&edition=fundamental","pubTime":"2025-11-08 10:01","pubTimestamp":1762567271,"startTime":"0","endTime":"0","summary":"Eric Venker, President & Immunovant CEO, reported a disposal of common shares of Roivant Sciences Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 07, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251108:nNDL2nRJC9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4588","IMVT","BK4585","BK4139","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":73,"code":"91000000","status":"200"}]}}